Pyxis Oncology Inc. (NASDAQ: PYXS)
$3.56
+0.3600 ( +11.25% ) 851.3K
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Market Data
Open
$3.56
Previous close
$3.20
Volume
851.3K
Market cap
$209.64M
Day range
$3.18 - $3.63
52 week range
$1.35 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 128 | Mar 21, 2024 |
8-k | 8K-related | 48 | Mar 21, 2024 |
8-k | 8K-related | 14 | Mar 13, 2024 |
3 | Insider transactions | 2 | Mar 13, 2024 |
4 | Insider transactions | 1 | Mar 13, 2024 |
8-k | 8K-related | 17 | Feb 28, 2024 |
4 | Insider transactions | 1 | Dec 29, 2023 |
3 | Insider transactions | 2 | Dec 06, 2023 |
4 | Insider transactions | 1 | Nov 30, 2023 |
8-k | 8K-related | 15 | Nov 28, 2023 |